Advertisement

Lasers and Light Sources for Medical Dermatologic Conditions

  • Michael H. Gold
Chapter

Abstract

  • Lasers and light sources have become more commonplace in the treatment of dermatologic medical diseases.

  • ALA-PDT is a proven therapy for actinic keratoses and superficial non-melanoma skin cancers.

  • ALA-PDT is being used to treat the signs of photorejuvenation with a variety of vascular lasers, blue light sources, and the intense pulsed light source.

  • PDT is a useful therapy for acne vulgaris with blue light and other light sources as well.

  • ALA-PDT is being used to treat moderate to severe acne vulgaris, andother sebaceous gland disorders with a variety of vascular lasers, blue light sources, and the intense pulsed light source.

  • New lasers and light sources are being used to treat psoriasis vulgaris, vitiligo, other disorders of pigmentation, and hypopigmented stretch marks.

Keywords

Sebaceous Gland Intense Pulse Light Hidradenitis Suppurativa Acne Lesion Inflammatory Acne 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

History of Photodynamic Therapy

  1. Ben-Hur E, Oetjen J, Horowitz B (1997) Silicon phthalocyanine Pc4 & red light causes apoptosis in HIV-infected cells. Photochem Photobiol 65:456–460PubMedCrossRefGoogle Scholar
  2. Bissonnette R, Lui H (1997) Current status of photodynamics therapy in dermatology. Dermatol Clin 15:507–519PubMedCrossRefGoogle Scholar
  3. Dinehart SM, Nelson-Adesokan P, Cockerell C et al (1997) Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 79:920–923PubMedCrossRefGoogle Scholar
  4. Dougherty TJ (1993) Photodynamnic therapy. Photochem Photobiol 58:895–900PubMedCrossRefGoogle Scholar
  5. Dougherty TJ, Kaufman JE, Goldfarb A et al (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38:2628–2635PubMedGoogle Scholar
  6. Dougherty TJ, Gomer CJ, Henderson BW, Kessel D, Korbelich M et al (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905PubMedCrossRefGoogle Scholar
  7. Figge FHJ, Weiland GS, Manganiello LDJ (1948) Cancer detection and therapy. Affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68:640PubMedGoogle Scholar
  8. Fritsch C, Lang K, Neuse W, Ruzicka T, Lehmann P (1998) Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 11:358–373PubMedGoogle Scholar
  9. Gomer CJ, Rucker N, Ferrario A, Wong S (1989) Properties and applications of photodynamic therapy. Radiat Res 100:1–18CrossRefGoogle Scholar
  10. Hendrich C, Siebert WE (1997) Photodynamic therapy for rheumatoid arthritis. J Lasers Surg Med 21:359–364CrossRefGoogle Scholar
  11. Hurwitz RM, Monger LE (1995) Solar keratoses: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 21:184PubMedCrossRefGoogle Scholar
  12. Jesionek A, Von Tappeiner H (1905) Behandlung der Hautcarcinome nut fluorescierenden Stoffen. Dtsch Arch Klin Med 85:223–227Google Scholar
  13. Kalka K, Merk H, Mukhtar H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42:389–413PubMedCrossRefGoogle Scholar
  14. Kennedy JC, Pottier RH, Pross DC et al (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143–148PubMedCrossRefGoogle Scholar
  15. Lefell DJ (2000) The scientific basis of skin cancer. J Am Acad Dermatol 42(1 pt 2):18–22CrossRefGoogle Scholar
  16. Lui H, Anderson RR (1993) Photodynamic therapy in dermatology: recent developments. Dermatol Clin 11:1–13PubMedCrossRefGoogle Scholar
  17. McCaughan JS, Guy JT, Hicks W, Laufman L, Nims TA, Walker J (1989) Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 124:211–216PubMedCrossRefGoogle Scholar
  18. McCaughan JS Jr, Brown DG, Hawley PC (1992) Photodynamic therapy: an eight year experience. In: Henderson BW, Dougherty TJ (eds) Photodynamic therapy: basic principle and clinical application. Marcel Dekker, New York, pp 323–331Google Scholar
  19. Pass HI, Delaney TF (1992) Innovative photodynamic therapy at the National Cancer Institute: intraoperative intracavity treatment. In: Henderson BW, Dougherty TJ (eds) Photodynamic therapy: basic principle and clinical application. Marcel Dekker, New York, pp 287–301Google Scholar
  20. Ratkay LB, Chowdhary RK, Damaroon A, Richter AM, Neyndorff HC, Keystone EC et al (1998) Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum 41:525–543PubMedCrossRefGoogle Scholar
  21. Rowe PM (1988) Photodynamic therapy begins to shine. Lancet 351:1496CrossRefGoogle Scholar
  22. Saito T, Hayashi J, Sato H, Kawabe H, Aizawa K (1996) Scanning electron micriscopic analysis of acute photodynamic therapy for atherosclerotic plaques of rabbit aorta using a pheophorbide derivative. J Clin Laser Med Surg 14:1–6PubMedGoogle Scholar
  23. Stables GI (1999) Photodynamic therapy in dermatology. J Dermatol Treat 10:213–219CrossRefGoogle Scholar
  24. Svaasand LO, Tromberg BJ, Wyss P et al (1996) Light and drug distribution with topically administered photosensitizers. Lasers Med Surg 11:261–265CrossRefGoogle Scholar
  25. Von Tappeiner H, Jodblauer A (1904) Ubner die Wirkung der photodynamischen (fluorescierenden) Staffe auf Protozoen und Enzyme. Dtsch Arch Klin Med 80:427–487Google Scholar

U.S. Experience for Actinic Keratoses with ALA-PDT

  1. Fowler J, Zax R (2002) Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcome and recurrence 4 years after treatment. Cutis 69:2–7PubMedGoogle Scholar
  2. Jeffes E (2002) Levulan®: the first approved topical photosensitizer for the treatment of actinic keratoses. J Dermatolog Treat 13(S):19–23CrossRefGoogle Scholar
  3. Jeffes E, McCullough J, Weinstein G et al (2001) Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 45:96–104PubMedCrossRefGoogle Scholar
  4. Ormrod D, Jarvis A (2000) Topical aminolevulinic acid HC1 photodynamic therapy. Am J Clin Dermatol 1(2):133–139PubMedCrossRefGoogle Scholar

New U.S. Indications for Photodynamic Photorejuvenation with ALA-PDT

  1. Alexiades-Armenakas M, Geronemus R (2003) Laser mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139:1313–1320PubMedCrossRefGoogle Scholar
  2. Alexiades-Armenakas MR, Geronemus RG (2004) Laser-mediated photodynamic therapy of actinic chelitis. J Drugs Dermatol 3(5):548–551PubMedGoogle Scholar
  3. Alster TS, Tanzi EL, Welch EC (2005) Photorejuvenation of facial skin with topical 20 % 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 4(1):35–38PubMedGoogle Scholar
  4. Avram D, Goldman MP (2004) Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 3(S):36–39Google Scholar
  5. Bissonnette R, Bergeson A, Lui H (2004) Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 3(S):26–31Google Scholar
  6. Dover JS, Bhatia AC, Stewart B et al (2005) Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 141(10):1247–1252PubMedCrossRefGoogle Scholar
  7. Gold MH (2002) The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis 69:8–13PubMedGoogle Scholar
  8. Gold MH. Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy. J Laser Med Surg. 2003;15(S):47.Google Scholar
  9. Gold MH, Bradshaw VL, Boring MM et al (2006) Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 32(6):795–801PubMedCrossRefGoogle Scholar
  10. Goldman MP, Atkin D, Kincad S (2002) PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Med Surg 14(S):24Google Scholar
  11. Key DJ (2005) Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmet Dermatol 18:31–36Google Scholar
  12. Marmur ES, Phelps R, Goldberg DJ (2005) Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 7:21–24PubMedCrossRefGoogle Scholar
  13. Redbord KP, Hanke CW (2007) Topical photodynamic therapy for dermatologic disorders: results and complications. J Drugs Dermatol 6(12):1197–1202PubMedGoogle Scholar
  14. Ruiz-Rodriquez R, Sanz-Sanchez T, Cordobo S (2002) Photodynamic photorejuvenation. Dermatol Surg 28:742–744CrossRefGoogle Scholar
  15. Touma D, Yaar M, Whitehead S et al (2004) A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140:33–40PubMedCrossRefGoogle Scholar
  16. Tschen EH, Wong DS, Pariser DM et al (2006) Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 155(6):1262–1269PubMedCrossRefGoogle Scholar

The European and Early USA Experience for Actinic Keratoses and Skin Cancers

  1. Braathen LR, Szeimies RM, Basset-Seguin N et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56:125–143PubMedCrossRefGoogle Scholar
  2. Freeman M, Vinciullo C, Francis D et al (2003) A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14:99–106PubMedCrossRefGoogle Scholar
  3. Gold MH (2008) 5-Aminolevulinic acid photodynamic therapy versus methyl aminolevulinate photodynamic therapy for inflammatory acne vulgaris. J Am Acad Dermatol 58(2):S60–S62PubMedCrossRefGoogle Scholar
  4. Harries MJ, Street G, Gilmour E et al (2007) Allergic contact dermatitis to methyl aminolevulinate (Metvix) cream used in photodynamic therapy. Photodermatol Photoimmunol Photomed 23(1):35–36PubMedCrossRefGoogle Scholar
  5. Hohwy T, Andersen KE, Sølvsten H et al (2007) Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients. Contact Dermatitis 57(5):321–323PubMedCrossRefGoogle Scholar
  6. Kashe A, Luderschmidt S, Ring J et al (2006) Photodynamic therapy induces less pain in patients treated with methyl aminolaevulinate compared to aminolaevulinate acid. J Drugs Dermatol 5(4):353–356Google Scholar
  7. Morton CA, McKenna KE, Rhodes LE et al (2008) Guidelines for topical photodynamic therapy: update. Br J Dermatol 159:1245–1266PubMedCrossRefGoogle Scholar
  8. Pariser DM et al (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48:227–232PubMedCrossRefGoogle Scholar
  9. Pariser D, Loss R, Jarratt M et al (2008) Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 59(4):569–576PubMedCrossRefGoogle Scholar
  10. Rhodes LE, de Rie M, Enström Y et al (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodulus basal cell carcinoma. Arch Dermatol 140:17–23PubMedCrossRefGoogle Scholar
  11. Wiegell SW, Wulf HC (2006) Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolaevulinate. J Am Acad Dermatol 54:647–651Google Scholar
  12. Wulf HC, Philipsen P (2004) Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not 5 aminolaevulinic acid after photodynamic therapy. Br J Dermatol 150:143–145PubMedCrossRefGoogle Scholar

Photodynamic Therapy for Acne Vulgaris

  1. (no authors) (2003) Med Lett Drug Ther 45(1159):50–51Google Scholar
  2. Elman M, Slatkine M, Harth Y (2003) The effective treatment of acne vulgaris by a high-intensity, narrow band 405–420 nm light source. J Cosmet Laser Ther 5:111–117PubMedCrossRefGoogle Scholar
  3. Elmcin M, Lebzelter J (2004) Light therapy in the treatment of acne vulgaris. Dermatol Surg 30:130–146CrossRefGoogle Scholar
  4. Gold MH. The utilization of ALA-PDT and a new photoclearing device for the treatment of severe inflammatory acne vulgaris – results of an initial clinical trial. J Lasers Surg Med. 2003;15(S):46.Google Scholar
  5. Gold MH. A multi-center investigatory study of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Am Acad Dermatol. 2004;50(S):56.Google Scholar
  6. Gold, MH. A multi-center study of photodynamic therapy in the treatment of moderate to severe inflammatory acne vulgaris with topical 20% 5-aminolevulinic acid and a new intense pulsed light source. J Am Acad Dermatol. 2004;50(S):54.Google Scholar
  7. Gold MH, Biron JA (2008) Efficacy of a novel combination of pneumatic energy and broadband light for the treatment of acne. J Drugs Dermatol 7(7):639–642PubMedGoogle Scholar
  8. Goldman MP (2003) Using 5-aminolevulinic acid to treat acne and sebaceous hyperplasia. Cosmet Dermatol 16:57–58Google Scholar
  9. Goldman MP, Boyce S (2003) A single-center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2:393–396PubMedGoogle Scholar
  10. Gollnick H, Cunliffe W, Berson D et al (2003) Management of acne: a report from a Global Alliance to improve outcomes in acne. J Am Acad Dermatol 49(1 Suppl):S1–S37PubMedCrossRefGoogle Scholar
  11. Heckbert SR, Lampe JW et al (2004) Antibiotic use in relation to the risk of breast cancer. JAMA 291:827–835PubMedCrossRefGoogle Scholar
  12. Hongcharu W, Taylor CR, Chang Y et al (2000) Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115(2):183–192PubMedCrossRefGoogle Scholar
  13. Horfelt C, Funk J, Frohm-Nilsson M et al (2006) Topicalmethyl aminolaevuninate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 155:608–613PubMedCrossRefGoogle Scholar
  14. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A (2000) Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 136(9):1093–1095PubMedCrossRefGoogle Scholar
  15. Itoh Y, Ninomiya Y, Tajima S et al (2001) Photodynamic therapy of acne vulgaris with topical delta aminolevulinic acid and incoherent light in Japanese patients. Br J Dermatol 144:575–579PubMedCrossRefGoogle Scholar
  16. Kawada A, Aragane Y, Kameyama H et al (2002) Acne phototherapy with a high-intensity, enhanced narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 30:129–135PubMedCrossRefGoogle Scholar
  17. Knulst AC, van Weelden H (1997) Phototherapy of acne vulgaris with visible light. Dermatology 194:256–260PubMedCrossRefGoogle Scholar
  18. Leyden JJ (1997) Therapy for acne vulgaris. N Engl J Med 336:1156–1162PubMedCrossRefGoogle Scholar
  19. Lloyd JR, Mirkov M (2002) Selective photothermolysis of the sebaceous glands for acne treatment. Lasers Surg Med 31:115–120PubMedCrossRefGoogle Scholar
  20. Paithankar DY, Ross EV, Saleh BA et al (2002) Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 31:106–114PubMedCrossRefGoogle Scholar
  21. Papageorgiou P, Katsambas A, Chu A et al (2000) Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 142:973–978PubMedCrossRefGoogle Scholar
  22. Rojanamatin J, Choawawanich P (2006) Treatment of inflammatory facial acne vulgaris with intense pulsed light (IPL) and short contact of topical 5-aminolevulinc acid (ALA): a pilot study. Dermatol Surg 32:991–997PubMedCrossRefGoogle Scholar
  23. Santos AV, Belo VG, Santos G (2005) Effectiveness of photodynamic therapy with topical 5-Aminolevulinic acid and intense pulsed light versus intense pulsed light along in the treatment of acne vulgaris: comparative study. Dermatol Surg 31(8 Pt 1):910–915PubMedGoogle Scholar
  24. Shamban AT, Enokibori M, Narurkar V et al (2008) Photopneumatic technology for the treatment of acne vulgaris. J Drugs Dermatol 7:139–145PubMedGoogle Scholar
  25. Wiegell SR, Wulf HC (2006) Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized controlled trial. Br J Dermatol 154:969–976Google Scholar

Photodynamic Therapy for Hidradenitis Suppurativa

  1. Gold MH, Bridges T, Bradshaw V et al (2004) ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3(S):32–39Google Scholar
  2. Rivard J, Ozog D (2006) Henry Ford Hospital dermatology experience with Levulan® Kerastick™ and blue light photodynamic therapy. J Drugs Dermatol 5(6):556–661PubMedGoogle Scholar
  3. Strauss RM, Pollock B, Stables GI et al (2005) Photodynamic therapy using aminolevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 152:803–804PubMedCrossRefGoogle Scholar

Photodynamic Therapy for Sebaceous Gland Hyperplasia

  1. Alster TS, Tanzi EL (2003) Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2(S):501–504PubMedGoogle Scholar
  2. Gold MH. A single center, open label investigator study of photodynamic therapy in the treatment of sebaceous gland hyperplasia with topical 20% 5-aminolevulinic acid with visible blue light or intense pulsed light. J Am Acad Dermatol. 2004;50(S):638.Google Scholar
  3. Horio T, Horio O, Miyauchi-Hashimoto H et al (2003) Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolevulinic acid and slide projector. Br J Dermatol 148:1274–1276PubMedCrossRefGoogle Scholar
  4. Richey DF, Hopson B. Treatment of sebaceous hyperplasia by photodynamic therapy. Personal communication 03/04.Google Scholar

Psoriasis Vulgaris

  1. Callen JP et al (2003) AAD consensus statement on psoriasis therapies. J Am Acad Dermatol 49(5):897–899PubMedCrossRefGoogle Scholar

Currently Available Technology

  1. Feldman SR (2002) Efficacy of 308 nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol 46(6):900–906PubMedCrossRefGoogle Scholar
  2. Tanghetti E. Personal communication 2002.Google Scholar
  3. Trehan M, Taylor CR (2002) High-dose 308 nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 46(4):732–737PubMedCrossRefGoogle Scholar

Vitiligo

  1. Spencer JM, Nossa R, Ajmeri J (2002) Treatment of vitiligo with the 308 nm excimer laser: a pilot study. J Am Acad Dermatol 40:727–731CrossRefGoogle Scholar

Hypopigmented Stretch Marks

  1. Gold MH. A new high intensity UV light source for the treatment of stretch marks. J Am Acad Dermatol. 2004;50(S):642.Google Scholar
  2. Sarradet D, Hussein M, Solana LG, Goldberg DJ (2002) Repigmentation of striae with a 308 nm excimer laser. Lasers Med Surg 14(S):44–45Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Gold Skin Care Center, Tennessee Clinical Research CenterNashvilleUSA
  2. 2.Department of Medicine, Division of DermatologyVanderbilt University School of Medicine and NursingNashvilleUSA
  3. 3.Huashan Hospital Fudan UniversityShanghaiChina
  4. 4.No. 1 Hospital of China Medical UniversityShenyangChina
  5. 5.First Peoples’s Hospital of FoshanGuangzhouChina

Personalised recommendations